P&F High Pole – FCT, FNB, FOF, FRX, FXA
by Yvonne Magtibay in Business on Sep 13, 2011
First Trust/Four Corners SFRI Fund II (NYSE:FCT) percentage change fell -1.84%, to close at $12.82 and its overall traded volume was 0.00 shares in the last trading session. FCT shares were trading within the range of $12.73-$13.12 while its opening price was $12.77. The stock has a 52 week low of $12.05 and 52 week high of $15.62. FCT’s market capitalization is $324.24M and it has 25.29M outstanding shares.
First Trust/Four Corners Senior Floating Rate Income Fund II (the Fund) is a diversified, closed-end management investment company. The Fund’s primary investment objective is to seek a high level of current income. As a secondary objective, the Fund seeks to preserve capital. The Fund will invest at least 80% of its managed assets in senior secured floating-rate corporate loans. The Fund invests in various industries, including media, healthcare providers and services, oil and gas, commercial services and supplies, electric utilities, information technology (IT) consulting and services, aerospace and defense, and hotels, restaurants and leisure. The Fund’s investment advisor is First Trust Advisors L.P. Its sub-advisor is Four Corners Capital Management, LLC.
F.N.B. Corporation (NYSE:FNB) gained 3.49%, to close at $8.59 and its overall traded volume was 1.08M shares in the last trading session. FNB opened the day at $8.16, it made an intraday low of $8.16 and an intraday high of $8.60. The stock has a 52 week range of $8.01 – $11.50. FNB’s market capitalization is $1.09B and it has 127.02M outstanding shares.F.N.B. Corporation is a financial holding company and a bank holding company. The Company has four business segments: Community Banking, Wealth Management, Insurance and Consumer Finance. Through its subsidiaries, it provides a range of financial services, principally to consumers and small to medium-sized businesses in its market areas. As of December 31, 2010, the Community Banking segment consisted of a regional community bank, First National Bank of Pennsylvania (FNBPA). The Wealth Management segment consisted of a trust company, a registered investment advisor and a subsidiary that offered broker-dealer services, through a th ird party networking arrangement with a non-affiliated licensed broker-dealer entity. The Insurance segment consisted of an insurance agency and a reinsurer. The Consumer Finance segment consisted of a multi-state consumer finance company. On January 1, 2011, the Company acquired Comm Bancorp, Inc (CBI).
Cohen & Steers Clsd-End Optuny Fnd, Inc. (NYSE:FOF) slid -0.65%, to close at $12.32 and its overall traded volume was 0.00 shares in the last trading session. FOF opened at $12.12 and is trading within the range of $12.03-$12.66. The 52-week range of the stock is $11.13 – $13.92. FOF’s market capitalization is $338.48M and it has 27.47M outstanding shares.Cohen & Steers Closed-End Opportunity Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is total return, consisting of high-current income and potential capital appreciation. It seeks to achieve its objective by investing in the common stock of closed-end funds, selected by Cohen & Steers, which invest significantly in equity or income-producing sectors, strategies and securities. The Fund invests in sectors, including equity tax advantaged securities, United States general equity, convertible securities, energy/resources and real estate. Cohen & Steers Capital Management, Inc. serves as the investment manager of the Fund.
Forest Laboratories, Inc. (NYSE:FRX) percentage change fell -0.55%, to close at $32.57 and its overall traded volume was 3.98M shares in the last trading session. FRX opened at $32.47 and is trading within the range of $32.08-$32.67. The stock has a 52 week low of $29.48 and 52 week high of $40.52. The market capitalization of the company stands at $8.94B and it has 274.56M outstanding shares.Forest Laboratories, Inc. (Forest) develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician’s prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company’s principal products include Lexapro, Namenda, Bystolic, Savella and Teflaro. On April 13, 2011, the Company ac quired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.
CurrencyShares Australian Dollar Trust (NYSE:FXA) fell -1.04%, to close at $103.59 and its overall traded volume was 383,507.00 shares in the last trading session. FXA opened at $103.52 and is trading within the range of $102.69-$103.97. The stock has a 52 week low of $92.50 and 52 week high of $110.99. FXA’s market capitalization is $853.14M.The CurrencyShares Australian Dollar Trust (the Trust) is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Australian Dollars and distributes Australian Dollars in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Australian Dollars plus accrued interest, if any, less the expenses of the Trust’s operations. The Shares are intended to offer investors an opportunity to participate in the market for the Australian Dollar through an investment in securities. The Shares are bought and sold on New York Stock Exch ange (NYSE) Arca like any other exchange-listed security.
Related Posts:
